Abbott
Laboratories (NYSE:ABT) slid 0.34% to $46.73. The 52-week range of the
stock is $44.59-$56.79.
Abbott
Laboratories (Abbott) is engaged in discovery, development, manufacture, and
sale of diversified line of healthcare products. The Company operates in four
segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products
and Vascular Products.
GlaxoSmithKline
plc (ADR) (NYSE:GSK) added 0.25% to $39.45. The 52-week range of
the stock is $32.15-$43.24.
GlaxoSmithKline
plc (GSK) is global healthcare group, which is engaged in the creation and
discovery, development, manufacture and marketing of pharmaceutical products,
including vaccines, over-the-counter (OTC) medicines and health-related
consumer products.
Mylan
Inc. (NASDAQ:MYL) is down 0.25% to $20.08. The 52-week range of
the stock is $16.55-$23.63. The stock is up more than 8% year-to-date.
The stock has average daily volume of 8.88 million shares.
Article published by Wall Street Grand. Visit the Wall Street Grand Club today.
For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
